U.K. Life Sciences Industry Challenges: The U.K. is recognized for its strong life sciences sector, housing major pharmaceutical companies like AstraZeneca and GSK, and top universities; however, tensions have arisen between the government and the industry over drug pricing, particularly due to a significant increase in rebate rates imposed by the health secretary.
Impact on Investment and Innovation: The heightened rebate rate has led industry leaders to express concerns about the U.K. becoming less attractive for investment, potentially diverting research and development efforts to the U.S., and hindering the launch of new medicines in the U.K. market.
PWP
$17.72+Infinity%1D
Analyst Views on PWP
Wall Street analysts forecast PWP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PWP is 19.00 USD with a low forecast of 19.00 USD and a high forecast of 19.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast PWP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PWP is 19.00 USD with a low forecast of 19.00 USD and a high forecast of 19.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
Current: 17.810
Low
19.00
Averages
19.00
High
19.00
Current: 17.810
Low
19.00
Averages
19.00
High
19.00
Keefe Bruyette
Market Perform
downgrade
$21 -> $19
2025-11-10
Reason
Keefe Bruyette
Price Target
$21 -> $19
2025-11-10
downgrade
Market Perform
Reason
Keefe Bruyette lowered the firm's price target on Perella Weinberg Partners to $19 from $21 and keeps a Market Perform rating on the shares.
Keefe Bruyette
Market Perform
maintain
$23 -> $24
2025-08-04
Reason
Keefe Bruyette
Price Target
$23 -> $24
2025-08-04
maintain
Market Perform
Reason
Keefe Bruyette raised the firm's price target on Perella Weinberg Partners to $24 from $23 and keeps a Market Perform rating on the shares.
Keefe Bruyette
Outperform -> Market Perform
downgrade
$22 -> $23
2025-07-13
Reason
Keefe Bruyette
Price Target
$22 -> $23
2025-07-13
downgrade
Outperform -> Market Perform
Reason
Keefe Bruyette downgraded Perella Weinberg Partners to Market Perform from Outperform with a price target of $23, up from $22, following a transfer of coverage. The firm believes the merger and acquisition environment should continue to improve gradually throughout the second half of the year. While policy and geopolitical uncertainty remain a risk, deal pipelines are still near all-time highs, the analyst tells investors in a research note. Keefe upgraded Houlihan Lokey and downgraded Perella Weinberg with the analyst change.
Wolfe Research
Outperform
maintain
$22 -> $25
2025-07-10
Reason
Wolfe Research
Price Target
$22 -> $25
2025-07-10
maintain
Outperform
Reason
Wolfe Research raised the firm's price target on Perella Weinberg Partners to $25 from $22 and keeps an Outperform rating on the shares. The firm has confidence in recommending alternative asset managers over the merger and acquisition brokers as a way to play the improving capital markets backdrop.
About PWP
Perella Weinberg Partners is an independent advisory company that provides strategic and financial advice to clients across active industry sectors and international markets. Its single business segment is to provide advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder engagement advisory, financing and capital solutions advice, with a focus on restructuring and liability management, capital markets advisory, and private capital placement, as well as specialized underwriting and research services for the energy and related industries. Its range of global clients includes large public multinational corporations, mid-sized public and private companies, financial sponsors, individual entrepreneurs, private and institutional investors, creditor committees and government institutions. Its areas of industry focus include consumer and retail, energy & energy transition, financial services & fintech, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
